Literature DB >> 18453103

Neutrophil isolation from nonhuman species.

Daniel W Siemsen1, Igor A Schepetkin, Liliya N Kirpotina, Benfang Lei, Mark T Quinn.   

Abstract

Advances in the understanding of neutrophil biochemistry require the development of effective procedures for isolating purified neutrophil populations. Although methods for human neutrophil isolation are now standard, similar procedures for isolating neutrophils from many of the nonhuman species used to model human diseases are not as well developed. Because neutrophils are reactive cells, the method of isolation is extremely important to avoid isolation technique-induced alterations in cell function. We present methods here for reproducibly isolating highly-purified neutrophils from large (cow, horse, sheep) and small (mouse, rabbit) animal models and describe optimized details for obtaining the highest cell purity, yield, and viability. We also describe methods to verify phagocytic capacity in the purified cell populations using a flow cytometry-based phagocytosis assay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18453103     DOI: 10.1007/978-1-59745-467-4_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  30 in total

1.  Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.

Authors:  Andrei I Khlebnikov; Igor A Schepetkin; Liliya N Kirpotina; Lars Brive; Claes Dahlgren; Mark A Jutila; Mark T Quinn
Journal:  J Mol Model       Date:  2011-11-30       Impact factor: 1.810

2.  TSP-1 Deficiency Alters Ocular Microbiota: Implications for Sjögren's Syndrome Pathogenesis.

Authors:  Marielle Terzulli; Laura Contreras-Ruiz; Laura Contreras Ruiz; Abirami Kugadas; Sharmila Masli; Mihaela Gadjeva
Journal:  J Ocul Pharmacol Ther       Date:  2015-05-26       Impact factor: 2.671

3.  Neutrophil isolation from nonhuman species.

Authors:  Daniel W Siemsen; Natalia Malachowa; Igor A Schepetkin; Adeline R Whitney; Liliya N Kirpotina; Benfang Lei; Frank R Deleo; Mark T Quinn
Journal:  Methods Mol Biol       Date:  2014

4.  Neutrophil transcriptional profile changes during transit from bone marrow to sites of inflammation.

Authors:  Flavia S Lakschevitz; Michelle B Visser; Chunxiang Sun; Michael Glogauer
Journal:  Cell Mol Immunol       Date:  2014-06-09       Impact factor: 11.530

5.  Role of Yersinia pestis toxin complex family proteins in resistance to phagocytosis by polymorphonuclear leukocytes.

Authors:  Justin L Spinner; Aaron B Carmody; Clayton O Jarrett; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2013-08-19       Impact factor: 3.441

6.  Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

Authors:  Dean Y Maeda; Mark T Quinn; Igor A Schepetkin; Liliya N Kirpotina; John A Zebala
Journal:  J Pharmacol Exp Ther       Date:  2009-09-24       Impact factor: 4.030

7.  Species-specific interaction of Streptococcus pneumoniae with human complement factor H.

Authors:  Ling Lu; Zhuo Ma; T Sakari Jokiranta; Adeline R Whitney; Frank R DeLeo; Jing-Ren Zhang
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice.

Authors:  Clare L Abram; Gray L Roberge; Lily I Pao; Benjamin G Neel; Clifford A Lowell
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

9.  Regulation of inhibition of neutrophil infiltration by the two-component regulatory system CovRS in subcutaneous murine infection with group A streptococcus.

Authors:  Jinquan Li; Hui Zhu; Wenchao Feng; Mengyao Liu; Yingli Song; Xiaolan Zhang; Yang Zhou; Weicheng Bei; Benfang Lei
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

10.  Immunomodulatory activity of oenothein B isolated from Epilobium angustifolium.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Larissa Jakiw; Andrei I Khlebnikov; Christie L Blaskovich; Mark A Jutila; Mark T Quinn
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.